CDTX - Cidara Therapeutics EPS beats by $0.08 August, 08 2019 05:05 PM Cidara Therapeutics Inc. Cidara Therapeutics (NASDAQ:CDTX): Q2 GAAP EPS of -$0.49 beats by $0.08.Cash, cash equivalents and short-term investments of $44.3MPress ReleaseMore news on: Cidara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,